Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 77
Filtrar
1.
J Exp Med ; 193(7): 803-14, 2001 Apr 02.
Artículo en Inglés | MEDLINE | ID: mdl-11283153

RESUMEN

Glucocorticoids (GCs) affect peripheral immune responses by inhibiting T cell immunity at several stages of the activation cascade, causing impaired cytokine production and effector function. The recent demonstration that the thymic epithelium and possibly thymocytes themselves produce steroids suggests that endogenous GCs also play a role in the control of T cell development. As both peripheral responsiveness and thymic differentiation appear to be regulated by the quantity and quality of intracellular signals issued by antigen-major histocompatibility complex-engaged T cell receptor (TCR) complexes, we investigated the effects of GCs on the signaling properties of T cells stimulated by anti-CD3 monoclonal antibodies or agonist peptides. We demonstrate in this work that dexamethasone, a synthetic GC, inhibits the early signaling events initiated upon TCR ligation, such as tyrosine phosphorylation of several TCR-associated substrates including the zeta chain, the ZAP70 kinase, and the transmembrane adapter molecule linker for activation of T cells. Hypophosphorylation was not a consequence of reduced kinase activity of src protein tyrosine kinases, but was correlated with an altered- membrane compartmentalization of these molecules. These observations indicate that in addition to their well-described ability to interfere with the transcription of molecules involved in peripheral responses, GCs inhibit T cell activation by affecting the early phosphorylating events induced after TCR ligation.


Asunto(s)
Dexametasona/farmacología , Glucocorticoides/farmacología , Inmunosupresores/farmacología , Receptores de Antígenos de Linfocitos T/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Linfocitos T/efectos de los fármacos , Animales , Regulación hacia Abajo/efectos de los fármacos , Hibridomas , Microdominios de Membrana/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Fosforilación/efectos de los fármacos , Timo/citología , Tirosina/metabolismo
2.
Eur Respir J ; 32(3): 678-86, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18480108

RESUMEN

Murine double minute clone 2 (MDM2), p14 alternate reading frame (p14arf), and nucleophosmin (NPM) regulate p53 activity. A total of 200 biopsies, including normal bronchial, pre-invasive and invasive tissues, were examined for changes in NPM, p14arf, MDM2 and p53 expression patterns by immunohistochemistry and immunofluorescence with confocal microscopy. NPM and p14arf displayed a diffuse nuclear staining in most normal bronchial tissue. The fraction of biopsies displaying an increased MDM2 staining or a nucleolar relocalisation of NPM increased at mild and moderate dysplasia, respectively. Two different modifications occurred in p14arf expression, i.e. its loss or its nucleolar relocalisation, both increasing at severe dysplasia and both being associated with high MDM2 expression. In addition, the nucleolar relocalisation of p14arf was associated with that of NPM. Immunofluorescence staining indicated that NPM and p14arf either co-localised in the nucleoplasm or in the nucleoli, before and as a result of severe dysplasia, respectively. MDM2 was not detected in the nucleoli. Thus, changes occur in murine double minute clone 2, p14 alternate reading frame and nucleophosmin level of expression and/or cellular distribution during early steps of lung carcinogenesis. Their relative localisation as determined by immunofluorescence, supports the hypothesis that p14 alternate reading frame nucleolar relocalisation impairs p14 alternate reading frame-murine double minute clone 2 complex formation and that nucleophosmin might sequester p14 alternate reading frame. The demonstration of this hypothesis requires further functional studies.


Asunto(s)
Neoplasias de los Bronquios/metabolismo , Carcinoma de Células Escamosas/metabolismo , Proteínas Nucleares/metabolismo , Proteínas Proto-Oncogénicas c-mdm2/metabolismo , Proteína p14ARF Supresora de Tumor/metabolismo , Neoplasias de los Bronquios/patología , Carcinoma de Células Escamosas/patología , Estudios de Casos y Controles , Nucléolo Celular/metabolismo , Humanos , Nucleofosmina
3.
Leukemia ; 21(4): 788-96, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17287851

RESUMEN

Adult T-cell leukemia/lymphoma (ATLL) is a malignancy slowly emerging from human T-cell leukemia virus type 1 (HTLV-I)-infected mature CD4(+) T-cells. To characterize the molecular modifications induced by HTLV-I infection, we compared HTLV-I-infected WE17/10 cells with control cells, using micro-arrays. Many calcium-related genes were progressively downmodulated over a period of 2 years. Infected cells acquired a profound decrease of intracellular calcium levels in response to ionomycin, timely correlated with decreased CD7 expression. Focusing on apoptosis-related genes and their relationship with CD7, we observed an underexpression of most antiapoptotic genes. Western blotting revealed increasing Akt and Bad phosphorylation, timely correlated with CD7 loss. This was shown to be phosphatidylinositol 3-kinase (PI3K)-dependent. Activation of PI3K/Akt induced resistance to the apoptotic effect of interleukin-2 deprivation. We thus propose the following model: HTLV-I infection induces a progressive decrease in CD3 genes expression, which eventually abrogates CD3 expression; loss of CD3 is known to perturb calcium transport. This perturbation correlates with loss of CD7 expression and induction of Akt and Bad phosphorylation via activation of PI3K. The activation of the Akt/Bad pathway generates a progressive resistance to apoptosis, at a time HTLV-I genes expression is silenced, thus avoiding immune surveillance. This could be a major event in the process of the malignant transformation into ATLL.


Asunto(s)
Antígenos CD7/genética , Linfocitos T CD4-Positivos/inmunología , Señalización del Calcio/fisiología , Transformación Celular Neoplásica , Infecciones por HTLV-I/fisiopatología , Proteína Oncogénica v-akt/genética , Proteína Letal Asociada a bcl/genética , Antígenos CD7/fisiología , Apoptosis , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/patología , Línea Celular , Citometría de Flujo , Regulación Viral de la Expresión Génica , Humanos , Ionomicina/farmacología , Proteína Oncogénica v-akt/fisiología , ARN/genética , ARN/aislamiento & purificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteína Letal Asociada a bcl/fisiología
4.
Mol Cell Biol ; 18(4): 2392-405, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9528808

RESUMEN

The human T-cell leukemia virus type 1 Tax protein transforms human T lymphocytes, which can lead to the development of adult T-cell leukemia. Tax transformation is related to its ability to activate gene expression via the ATF/CREB and the NF-kappaB pathways. Transcriptional activation of these pathways is mediated by the actions of the related coactivators CREB binding protein (CBP) and p300. In this study, immunocytochemistry and confocal microscopy were used to localize CBP and p300 in cells expressing wild-type Tax or Tax mutants that are able to selectively activate gene expression from either the NF-kappaB or ATF/CREB pathway. Wild-type Tax colocalized with both CBP and p300 in nuclear bodies which also contained ATF-1 and the RelA subunit of NF-kappaB. However, a Tax mutant that selectively activates gene expression from only the ATF/CREB pathway colocalized with CBP but not p300, while a Tax mutant that selectively activates gene expression from only the NF-kappaB pathway colocalized with p300 but not CBP. In vitro and in vivo protein interaction studies indicated that the integrity of two independent domains of Tax delineated by these mutants was involved in the direct interaction of Tax with either CBP or p300. These studies are consistent with a model in which activation of either the NF-kappaB or the ATF/CREB pathway by specific Tax mutants is mediated by distinct interactions with related coactivator proteins.


Asunto(s)
Regulación Viral de la Expresión Génica , Productos del Gen tax/metabolismo , Virus Linfotrópico T Tipo 1 Humano/fisiología , Proteínas Nucleares/metabolismo , Proteínas Represoras , Transactivadores , Factores de Transcripción/metabolismo , Activación Transcripcional , Factor de Transcripción Activador 1 , Animales , Sitios de Unión , Proteína de Unión a CREB , Línea Celular , Núcleo Celular/metabolismo , Transformación Celular Viral , Cricetinae , Modulador del Elemento de Respuesta al AMP Cíclico , Proteínas de Unión al ADN/metabolismo , Productos del Gen tax/genética , Virus Linfotrópico T Tipo 1 Humano/genética , Humanos , Mutación , FN-kappa B/metabolismo , Factor de Transcripción ReIA , Transcripción Genética , Células Tumorales Cultivadas
5.
Mol Cell Biol ; 18(7): 4221-34, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9632806

RESUMEN

Regulation of the IkappaB alpha and IkappaB beta proteins is critical for modulating NF-kappaB-directed gene expression. Both IkappaB alpha and IkappaB beta are substrates for cellular kinases that phosphorylate the amino and carboxy termini of these proteins and regulate their function. In this study, we utilized a biochemical fractionation scheme to purify a kinase activity which phosphorylates residues in the amino and carboxy termini of both IkappaB alpha and IkappaB beta. Peptide microsequence analysis by capillary high-performance liquid chromatography ion trap mass spectroscopy revealed that this kinase was the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). DNA-PK phosphorylates serine residue 36 but not serine residue 32 in the amino terminus of IkappaB alpha and also phosphorylates threonine residue 273 in the carboxy terminus of this protein. To determine the biological relevance of DNA-PK phosphorylation of IkappaB alpha, murine severe combined immunodeficiency (SCID) cell lines which lack the DNA-PKcs gene were analyzed. Gel retardation analysis using extract prepared from these cells demonstrated constitutive nuclear NF-kappaB DNA binding activity, which was not detected in extracts prepared from SCID cells complemented with the human DNA-PKcs gene. Furthermore, IkappaB alpha that was phosphorylated by DNA-PK was a more potent inhibitor of NF-kappaB binding than nonphosphorylated IkappaB alpha. These results suggest that DNA-PK phosphorylation of IkappaB alpha increases its interaction with NF-kappaB to reduce NF-kappaB DNA binding properties.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Proteínas I-kappa B , FN-kappa B/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Células 3T3 , Secuencia de Aminoácidos , Animales , Línea Celular , Núcleo Celular/metabolismo , ADN/metabolismo , Proteína Quinasa Activada por ADN , Proteínas de Unión al ADN/genética , Células HeLa , Humanos , Ratones , Ratones SCID , Datos de Secuencia Molecular , Inhibidor NF-kappaB alfa , Subunidad p50 de NF-kappa B , Proteínas Nucleares , Fosforilación , Proteínas Serina-Treonina Quinasas/aislamiento & purificación , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Factor de Transcripción ReIA
6.
Cancer Res ; 39(3): 1118-23, 1979 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-218722

RESUMEN

In this study, 345 cattle from 7 herds with a history of lymphosarcoma were tested for antibody to BLV antigens by three serological methods, namely immunodiffusion using a bovine leukemia virus glycoprotein with a molecular weight of 60,000 as antigen, and radioimmunoassay using a bovine leukemia virus glycoprotein with a molecular weight of 60,000 and a bovine leukemia virus protein with a molecular weight of 24,000 as antigen. The three tests under comparison agreed for 335 animals, 240 being negative in the three tests, and 95 being positive. Results were variable in ten cases only. Glycoprotein with a molecular weight of 60,000 antibody titers were systematically higher than were protein with a molecular weight of 24,000 antibody titers in bovine sera and milk, as well as in sera of experimentally infected sheep. In the latter case, antibodies to bovine leukemia virus antigens reached maximal values at the animal death in the tumor phase of the disease. Ratios of serum antiglycoprotein titer to milk titer varied between 4 and 117, showing that, if milk pools are to be used in surveys of bovine leukemia virus infection, use of very sensitive techniques of detection is mandatory.


Asunto(s)
Anticuerpos Antivirales/biosíntesis , Virus de la Leucemia Bovina/inmunología , Leucemia Experimental/inmunología , Retroviridae/inmunología , Animales , Anticuerpos Antivirales/análisis , Antígenos Virales , Bovinos , Femenino , Glicoproteínas/inmunología , Inmunodifusión , Leche/inmunología , Radioinmunoensayo , Ovinos , Proteínas Virales/inmunología
7.
J Mol Biol ; 189(2): 293-303, 1986 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-3018261

RESUMEN

Mini-F is a segment of the conjugative plasmid F consisting of two origins of replication flanked by regulatory regions, which ensure a normal control of replication and partitioning. Adjacent to the ori-2 origin is a complex coding region that consists of the E gene overlapped by three open reading frames with the coding potential for 9000 Mr polypeptides here designated 9 kd-1, 9 kd-2 and 9 kd-3. In this paper, we show that open reading frame 9 kd-3 is preceded by active promoter and Shine-Dalgarno sequences. The E coding region specifies: an initiator of replication, which acts at the ori-2 site; a function that negatively regulates the expression of the E gene; and a function involved in mini-F copy number control. To assign one of these functions to one of the overlapping coding sequence, we have isolated, characterized and sequenced mutations mapping in the E coding region. In this paper, we analyse two mutations (cop5 and pla25) that abolish the repression of the E gene. As these mutations affect the primary structure of protein E itself but not the 9 kd polypeptides, we conclude that protein E takes part in the negative regulation of its own synthesis. In addition, the localization of the cop5 and pla25 mutations indicates that the carboxy-terminal end of the E protein is involved in the autorepression function. The cop5 mutation causes an eightfold increase of the mini-F copy number. The pla25 mutation leads to the inability of the derived mini-F plasmid to give rise to plasmid-harbouring bacteria. The ways in which the cop5 and pla25 mutations may lead to such phenotypes are discussed in relation to the different functions mapping in the E coding sequence.


Asunto(s)
Proteínas Bacterianas , Escherichia coli/genética , Factor F , Regulación de la Expresión Génica , Genes Bacterianos , Secuencia de Aminoácidos , Secuencia de Bases , ADN Bacteriano , Electroforesis en Gel de Agar , Focalización Isoeléctrica , Mutación , Biosíntesis de Proteínas
8.
Endocrinology ; 100(4): 1223-6, 1977 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-837885

RESUMEN

Suppression of testicular weight and activity induced in the hamster by light deprivation can be partially reversed by treatment with prolactin (PRL). The present study investigates the possibility that the stimulatory effect of PRL in this preparation may be mediated through increased LH binding. Hamsters exposed to 5 h light per day for two months to induce gonadal atrophy were injected daily for 2 1/2 weeks with saline, 250 mug PRLP, 20 MUG LH+150 mug FSH, or PRL+LH+FSH. Short light control animals exhibited significantly less LH binding than controls on 14 h of light per day. Treatment with LH+FSH had no effect on LH binding while PRL alone or in combination with LH+FSH increased binding to levels greater than the long light controls. Peripheral testosterone concentrations reflected the level of LH binding. Scatchard analysis indicates that the decreased binding in the short-day animals is due to reduced LH receptor numbers and that PRL treatment elevates receptor levels thereby increasing LH binding. These results suggest that the mechanism by which PRL stimulates testicular function in hamsters with regressed gonads is through increased binding of endogenously produced LH.


Asunto(s)
Hormona Luteinizante/metabolismo , Prolactina/farmacología , Testículo/metabolismo , Animales , Cricetinae , Oscuridad , Hormona Folículo Estimulante/farmacología , Luz , Hormona Luteinizante/farmacología , Masculino , Testículo/efectos de los fármacos , Testosterona/metabolismo
9.
Endocrinology ; 96(4): 928-33, 1975 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1168126

RESUMEN

Hamster serum gonadotropins were measured by RIA at 4 h intervals during the estrous cycle. On the afternoon of proestrus both LH and FSH exhibited a surge, but unlike the situation in the rat and mouse FSH returned to "baseline" with LH by early evening of proestrus. Shortly following this return FSH concentrations increased and reached a second peak by noon on estrus which was equal in magnitude and longer in duration than that occurring on proestrus. FSH fell to its lowest levels on diestrus 2 (D2) and early proestrus. Serum gonadotropins were measured by RIA 6 h following unilateral ovariectomy on D2. A slight elevation of LH resulted while FSH increased to a level equal in magnitude to that found during the proestrous surge. In intact females administration of a total of 45 mug FSH in 5 injections on D2 resulted in ovulation of twice the normal number of eggs. The t1/2 of this rat FSH in the male hamster was found to be 122 minutes. The low levels of FSH during the cycle between D2 and proestrus, the large increase in serum FSH following unilateral ovariectomy, and the "doubled" ovulation in intact hamsters following the administration of FSH on D2, suggest that the serum FSH concentration on D2 is critical in determining the number of follicles which will be available for the subsequent ovulation.


Asunto(s)
Cricetinae/fisiología , Hormona Folículo Estimulante/sangre , Hormona Luteinizante/sangre , Ovulación , Animales , Castración , Estro , Femenino , Hormona Folículo Estimulante/metabolismo , Hormona Folículo Estimulante/farmacología , Semivida , Masculino , Ovario/fisiología , Ovulación/efectos de los fármacos , Embarazo
10.
Endocrinology ; 103(6): 2069-80, 1978 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-218802

RESUMEN

In adult male hamsters, 2 months of exposure to a short photoperiod (5 h of light:19 h of darkness) caused testicular regression and a precipitous decline in plasma PRL, in agreement with earlier reports from other laboratories. Depressed release of PRL cannot be explained by a reduction in testicular steroidogenesis, because castration of males kept in a long photoperiod did not reduce PRL levels and administration of testosterone to males kept in a short photoperiod failed to reverse the decline in plasma PRL concentration. Treatment of such "regressed" animals with PRL, GH, or ectopic pituitary transplants stimulated growth of the testes and the accessory reproductive glands, increased the concentration of LH receptors in the testes, and elevated plasma testosterone levels. A single injection of 250 microgram PRL was sufficient to increase testicular LH binding, and chronic treatment with pituitary grafts completely reversed testicular regression. The effectiveness of exogenous PRL in stimulating testicular growth and LH receptors was significantly influenced by the timing of the injection. In some experiments, gonadotropin levels appeared elevated in animals injected with PRL, but these differences were not statistically significant. In hamsters with gonadal regression induced by exposure to a short photoperiod, daily administration of 20 microgram H and/or 150 microgram FSH had no apparent effect on testicular function. However, treatment with large doses of hCG and/or PMS gonadotropin resulted in significant stimulation of testicular growth and steroidogenesis. Chronic treatment of males maintained in a long photoperiod (14 h of light:10 h of darkness) with an inhibitor of PRL release, 2-Br-alpha-ergocryptine, resulted in a decreased weight of the testes and seminal vesicles. Administration of this inhibitor for a longer period (2 months) produced a significant increase in body weight but had little effect on testicular function. These results indicate that changes in the release of PRL (and possibly also GH) may plan an important role in mediating the effects of the photoperiod on testicular function in the golden hamster.


Asunto(s)
Hormona del Crecimiento/farmacología , Hormona Luteinizante/metabolismo , Prolactina/farmacología , Receptores de Superficie Celular/metabolismo , Estaciones del Año , Testículo/fisiología , Animales , Castración , Cricetinae , Oscuridad , Femenino , Hormona del Crecimiento/sangre , Luz , Masculino , Hipófisis/trasplante , Prolactina/sangre , Testículo/efectos de los fármacos , Testosterona/farmacología , Trasplante Homólogo
11.
Endocrinology ; 106(1): 167-72, 1980 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-6243094

RESUMEN

Transfer of adult male hamsters from a long to a short photoperiod causes testicular atrophy, which is accompanied by decreases in testicular LH receptors and in plasma PRL and testosterone levels. A decrease in plasma gonadotropin levels is also frequently observed. When the decline in peripheral PRL concentration is prevented by transplantation of homologous pituitary(ies) under the kidney capsule, testicular atrophy is delayed and incomplete. This appears to be due to the maintenance of testicular LH receptors by PRL secreted from the grafts and probably also to the stimulation of GSH release from the in situ pituitary. In hamsters maintained in a long photoperiod, ectopic pituitary homografts can increase testicular LH receptor levels, concentrations of testosterone and FSH in the plasma, and the weights of the testes and the seminal vesicles. In contrast to the findings obtained in rats and mice, chronic hyperprolactinemia in the male hamster does not inhibit gonadotropin release or interfere with copulatory behavior. These findings are consistent with our earlier suggestion that PRL plays an important part in the regulation of gonadal function in the male hamster but indicate that testicular atrophy in a short photoperiod cannot be explained solely by a reduction in PRL release.


Asunto(s)
Prolactina/farmacología , Testículo/patología , Animales , Atrofia , Cricetinae , Hormona Luteinizante/metabolismo , Masculino , Mesocricetus , Tamaño de los Órganos/efectos de los fármacos , Hipófisis/trasplante , Prolactina/sangre , Receptores de Superficie Celular/fisiología , Vesículas Seminales/fisiopatología , Conducta Sexual Animal/efectos de los fármacos , Testículo/efectos de los fármacos , Testículo/fisiopatología , Trasplante Homólogo
12.
Bone ; 35(1): 162-9, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15207752

RESUMEN

The mutation responsible for the high bone mass (HBM) phenotype has been postulated to act through the adaptive response of bone to mechanical load resulting in denser and stronger skeletons in humans and animals. The bone phenotype of members of a HBM family is characterized by normally shaped bones that are exceptionally dense, particularly at load bearing sites [Cancer Res. 59 (1999) 1572]. The high bone mass (HBM) mutation was identified as a glycine to valine substitution at amino acid residue 171 in the gene coding for low-density lipoprotein receptor-related protein 5 (LRP5) [Bone Miner. Res. 16(4) (2001) 758]. Thus, efforts have focused on the examination of the role of LRP5 and the G171V mutation in bone mechanotransduction responses [J. Bone Miner. Res 18 (2002) 960]. Transgenic mice expressing the human G171V mutation have been shown to have skeletal phenotypes remarkably similar to those seen in affected individuals. In this study, we have identified differences in biomechanical (structural and apparent material) properties, bone mass/ash, and bone stiffness of cortical and cancellous bone driven by the G171V mutation in LRP5. As in humans, the LRP5 G171V plays an important role in regulating bone structural phenotypes in mice. These bone phenotypes include greater structural and apparent material properties in HBM HET as compared to non-transgenic littermates (NTG) mice. Body size and weight in HBM HET were similar to that in NTG control mice. However, the LRP5 G171V mutation in HET mice results in a skeleton that has greater structural (femoral shaft, femoral neck, tibiae, vertebral body) and apparent material (vertebral body) strength, percent bone ash weight (ulnae), and tibial stiffness. Despite similar body weight to NTG mice, the denser and stiffer bones in G171V mice may represent greater bone formation sensitivity to normal mechanical stimuli resulting in an overadaptation of skeleton to weight-related forces.


Asunto(s)
Densidad Ósea/genética , Huesos/fisiología , Proteínas Relacionadas con Receptor de LDL/genética , Sustitución de Aminoácidos , Animales , Fenómenos Biomecánicos , Peso Corporal , Femenino , Proteínas Relacionadas con Receptor de LDL/metabolismo , Proteína-5 Relacionada con Receptor de Lipoproteína de Baja Densidad , Masculino , Ratones , Ratones Transgénicos , Fenotipo
13.
Biochimie ; 59(1): 79-84, 1977.
Artículo en Inglés | MEDLINE | ID: mdl-192324

RESUMEN

A mutant of Saccharomyces cerevisiae, unable to grow at the expense of non fermentable carbon sources at 37 degrees C, has been selected; at 25 degrees C the mutant strain behaves like the parental wild strain. Evaluations of respiration rates during aerobic growth at restrictive temperature on one hand, enzymatic and/or spectral evaluations of the individual components of the respiratory chain on the other hand show that the respiratory deficiency is specifically correlated with a reduced level of cytochrome oxidase. The decrease of enzyme activity is the direct consequence of a lowering of hemoprotein (a,a3) concentration. Temperature-activity relationship of cytochrome oxidase elaborated at the permissive temperature by the mutant strain is modified as far as the particulate enzyme is concerned, but no difference is observed after partial solubilization of the enzyme by non ionic surfactant. Genetic analysis shows that the mutant phenotype results from a nuclear gene mutation.


Asunto(s)
Complejo IV de Transporte de Electrones/metabolismo , Consumo de Oxígeno , Saccharomyces cerevisiae/enzimología , Aerobiosis , División Celular , Membrana Celular/enzimología , Complejo IV de Transporte de Electrones/aislamiento & purificación , Etanol/metabolismo , Glucosa/metabolismo , Glicerol/metabolismo , Calor , Cinética , Lactatos/metabolismo , Mutación , Esporas Fúngicas/metabolismo
14.
AIDS Res Hum Retroviruses ; 8(4): 435-42, 1992 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1599753

RESUMEN

Sixteen children over the age of 5 years (Group 1) have been identified out of 537 children infected by human immunodeficiency virus and born to HIV-infected mothers, in Kigali, Rwanda. They were followed up for 2 years and compared with 16 younger AIDS patients (Group 2) and with 16 age- and gender-matched HIV-1 seronegative children (Group 3). Fourteen Group 1 subjects had anti-HIV-1 IgM which persisted during the entire study period, in 11 cases directed to HIV-1 envelope proteins. In vitro, immortalization of B lymphocytes by the Epstein-Barr virus confirmed a high production of IgM to envelope proteins. All these patients had anti-p 17 IgG which was not observed in 7 patients from Group 2. All 16 children mounted significant titers of neutralizing antibodies to HTLV-IIIB, and, in 8 patients tested, against two other HIV-1 strains, RII and MN. HIV-1-specific major histocompatibility complex (MHC)-restricted cytotoxic T cells were demonstrated in 3 of 5 of the subgroup who were tested. Prolonged survival over 5 years in children with maternally acquired HIV-1 infection is associated with a high titer of neutralizing antibodies, a persistent production of IGM to HIV-1 envelope proteins and of IgG to p 17.


Asunto(s)
Infecciones por VIH/epidemiología , VIH-1 , Citotoxicidad Celular Dependiente de Anticuerpos , Biomarcadores , Western Blotting , Niño , Preescolar , Citotoxicidad Inmunológica , Anticuerpos Anti-VIH/inmunología , Infecciones por VIH/inmunología , Infecciones por VIH/transmisión , VIH-1/inmunología , Humanos , Pruebas de Neutralización , Rwanda/epidemiología , Análisis de Supervivencia , Linfocitos T Citotóxicos/inmunología
15.
Biochem Pharmacol ; 58(10): 1567-78, 1999 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-10535747

RESUMEN

The ability of full-length human recombinant osteopontin (OPN) to support the adhesion of various alphav integrin-expressing cell lines was determined in order to characterize its integrin selectivity. The identity of this protein was assessed by cDNA sequence and mass spectroscopic analysis, and confirmed as full-length OPN. Neither the human embryonic kidney 293 cell line, which expresses the alphavbeta1 integrin, nor the human colonic adenocarcinoma HT-29 cell line, which expresses the alphavbeta5 integrin, were able to adhere to OPN; both of these cell lines are deficient in the beta3 subunit. In contrast, an alphavbeta3 integrin-expressing cell line, SK-MEL-24, was able to adhere to OPN in an arginine-glycine-aspartic acid dependent manner. In addition, this OPN-mediated cellular adhesion was completely blocked with an anti-alphavbeta3 integrin antibody (LM609), confirming that only the alphavbeta3 integrin mediated this cellular adhesion. These data demonstrate that, at least among the alphav integrins, only the alphavbeta3 is able to support cellular adhesion to osteopontin. This finding may have implications for the design of therapeutics targeting OPN-integrin interactions.


Asunto(s)
Adhesión Celular/efectos de los fármacos , Receptores de Vitronectina/metabolismo , Sialoglicoproteínas/farmacología , Línea Celular , Matriz Extracelular/fisiología , Células HT29 , Humanos , Oligopéptidos/fisiología , Osteopontina , Conformación Proteica , Receptores de Vitronectina/biosíntesis , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacología , Sialoglicoproteínas/metabolismo , Células Tumorales Cultivadas
16.
Life Sci ; 35(9): 969-79, 1984 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-6433130

RESUMEN

Further confirmation that the LHRH/LHRH agonist-induced ovulation in the hypophysectomized (hypx) rat is due to a direct ovarian effect and not mediated by LH release from residual pituitary tissue or other CNS sites is provided by the persistence of this effect despite concomitant median eminence lesion or passive immunization to LH. Adrenalectomy did not affect the ovulatory activity of the LHRH agonist, D-Trp6-N alpha MeLeu7-DesGly10-Pro9-NHEt-LHRH (Wy-40,972), in the hypx rat. Prior administration of a potent LHRH antagonist blocked ovulation induced in hypx proestrous rats by Wy-40,972 but not by LH-S19. Ovulation can be induced by Wy-40,972 one day earlier (e.g. metestrus) in the intact rat than it can in the hypx rat. Results in the hypx metestrous rat indicate that the ovulatory responsiveness of the intact rat at this stage of the cycle may occur by complementary action of Wy-40,972-stimulated endogenous LH release and a direct ovarian effect of the agonist. Prostaglandins (PG) are involved in the ovulatory mechanism of Wy-40,972 in the hypx proestrous rat as evidenced by the dose-dependent inhibition of this effect by PG synthetase inhibitors, indomethacin and Fentiazac. Moreover, there were significant increases in ovarian concentrations of PGF2 alpha and PGE2-PGE1 in response to Wy-40,972 that could be prevented by indomethacin. However, exogenous administration of either of these PG's was not effective in inducing ovulation in the hypx rat.


Asunto(s)
Inhibidores de la Ciclooxigenasa , Hormona Liberadora de Gonadotropina/análogos & derivados , Hormona Liberadora de Gonadotropina/antagonistas & inhibidores , Hipofisectomía , Inducción de la Ovulación , Tiazoles , Acetatos/farmacología , Adrenalectomía , Animales , Dinoprost , Estro/efectos de los fármacos , Femenino , Hormona Liberadora de Gonadotropina/farmacología , Indometacina/farmacología , Hormona Luteinizante/inmunología , Eminencia Media/fisiología , Pentobarbital/farmacología , Embarazo , Prostaglandinas E/farmacología , Prostaglandinas F/farmacología , Ratas , Ratas Endogámicas
17.
Life Sci ; 30(15): 1263-9, 1982 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-7045558

RESUMEN

In the mouse, the LH-releasing activity of the LHRH agonist, D-Trp6-N alpha-MeLeu7-DesGly10-Pro9-NHEt-LHRH (Wy-40,972), was established by its ability both to induce ovulation when administered at 1600 hours on the the second day of diestrus and to elevate serum LH in adult males. While Wy-40,972 was only slightly less active in terms of these and points than it was in the rat, the predictive and possibly causal association between LH-releasing and antifertility activity established for this LHRH analog in the rat could not be clearly identified in the mouse. A total daily dose of 1000 microgram Wy-40,972/mouse was required to completely inhibit pregnancy during days 1-7 of pregnancy and produced only partial inhibition during days 7-12. This dose represents, on a body weigh basis, 8250 times the 100 percent effective pregnancy-terminating dose for the rat during equivalent intervals. The resistance of the mouse to the antifertility activity of Wy-40,972 was found not to be restricted to this particular LHRH analog or to the reproductive state. Administration of another potent LHRH analog, D-Ala6-DesGly10-Pro9-NHEt-LHRH (Wy-18,481), to adult male mice at a dose of 100 microgram/mouse/day for up to 14 days had no inhibitory effect on the weights of the testes or sex accesory organs. This dose of Wy-18,481 is 7500 times that necessary for significant reduction of these reproductive organ weights in rats within 7 days of treatment. Investigation as to the nature of the mouse's apparently divergent response to the LHRH agonists may further elucidate the antifertility mechanism of such compounds in susceptible species.


Asunto(s)
Fertilidad/efectos de los fármacos , Hormona Liberadora de Gonadotropina/análogos & derivados , Ratones/fisiología , Animales , Resistencia a Medicamentos , Femenino , Hormona Liberadora de Gonadotropina/farmacología , Hormonas/farmacología , Masculino , Embarazo , Ratas , Ratas Endogámicas , Factores de Tiempo
18.
Pharmacol Biochem Behav ; 24(6): 1573-6, 1986 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-2942948

RESUMEN

The present study examined the effects of ANF(4-28) [Wy-47,663], a synthetic 25 amino acid human atrial natriuretic factor, on the dipsogenic actions of centrally-administered angiotensin II in conscious rats. Bolus injection (100 ng) or continuous infusion (60 ng/min) of Wy-47,663 or vehicle into the lateral cerebroventricle had no effect on mean arterial pressure or heart rate. No obvious behavioral changes were observed after central administration of Wy-47,663 or vehicle. Central injection of angiotensin II (15 or 30 ng) promptly elicited prolonged drinking responses in vehicle-treated rats. In rats pretreated with Wy-47,663, the onset of the angiotensin II-induced drinking responses was significantly delayed compared to vehicle-treated animals. However, Wy-47,663 had no effect on the total volume consumed over 30 minutes after angiotensin II injection. Intravenous infusion of Wy-47,663 (2 micrograms/kg/min) failed to alter the dipsogenic action of centrally administered angiotensin II. These data indicate that atrial natriuretic factor found within the brain but not the peripheral circulation may participate in the regulation of extracellular fluid volume by modulating the dipsogenic actions of the central renin-angiotensin system.


Asunto(s)
Angiotensina II/farmacología , Factor Natriurético Atrial/farmacología , Encéfalo/efectos de los fármacos , Ingestión de Líquidos/efectos de los fármacos , Animales , Factor Natriurético Atrial/sangre , Presión Sanguínea/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Inyecciones Intraventriculares , Masculino , Ratas , Ratas Endogámicas
19.
Int J Gynaecol Obstet ; 16(5): 359-72, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-35404

RESUMEN

A prototype LH-RH antagonist dampened the proestrous gonadotropin surge and blocked ovulation but had no effect on pregnant animals. In contrast, LH-RH and two highly potent LH-RH agonists terminated pregnancy when administrated prior to or following implantation. This contragestational effect, as well as other antireproductive properties of the agonists, coupled with the reversibility of their effects, strongly suggest that peptides may provide a new basis for contraception.


Asunto(s)
Anticonceptivos Femeninos/farmacología , Hormona Liberadora de Gonadotropina/análogos & derivados , Administración Oral , Animales , Anticonceptivos Sintéticos Poscoito , Copulación , Estro , Femenino , Genitales Masculinos/efectos de los fármacos , Hormona Liberadora de Gonadotropina/administración & dosificación , Hormona Liberadora de Gonadotropina/farmacología , Inyecciones Intramusculares , Inyecciones Subcutáneas , Masculino , Ovulación/efectos de los fármacos , Embarazo , Proestro/efectos de los fármacos , Conejos , Ratas , Útero/efectos de los fármacos
20.
Am J Vet Res ; 46(12): 2582-4, 1985 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-3909866

RESUMEN

Hybridizations were done on bovine enterotoxigenic Escherichia coli with 2 heat-stable (ST) enterotoxin gene probes from porcine and human origin (STp and STh). Of the baby mouse-positive isolates, 56 (53%) hybridized the STp probe and 50 (47%) did not. There was no isolate that hybridized the STh probe. Hybridization with the Stp probe was more frequent (P less than 0.005) for E coli isolated from calves that died before 2 weeks of age (49 STp-positive isolates of 77 [64%] isolates) than for E coli isolated from calves that died after 2 weeks of age (2 STp-positive of 21 [10%] isolates).


Asunto(s)
Toxinas Bacterianas/genética , Enterotoxinas/genética , Escherichia coli/genética , Genes Bacterianos , Animales , Animales Recién Nacidos , Bovinos , Enfermedades de los Bovinos/microbiología , ADN Bacteriano/genética , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/veterinaria , Proteínas de Escherichia coli , Humanos , Ratones , Hibridación de Ácido Nucleico , Porcinos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda